Literature DB >> 7847427

Medically safe rate of weight loss for the treatment of obesity: a guideline based on risk of gallstone formation.

R L Weinsier, L J Wilson, J Lee.   

Abstract

OBJECTIVE: Currently recommended rates of weight loss for obese persons are not based on demonstrated health risks. The authors attempt to determine a medically safe rate of weight loss based on currently available data on the risk of gallstone formation during active weight loss.
METHODS: All prospective studies published in the English language on the formation of gallstones in obese persons during active weight loss were reviewed and evaluated. A statistical analysis was performed using studies of at least 4 weeks' duration that included information on diet composition, rates of weight loss, length of follow-up, and incidence of gallstone formation. A statistical model was fit to the data from the studies that met the criteria.
RESULTS: Nine subject groups derived from five published reports met the criteria for inclusion in the analysis. When the results of these groups were evaluated statistically, a curvilinear relationship between incidence of gallstone formation and rate of weight loss was demonstrated. The relationship was best described by an exponential regression curve, with an adjusted r2 of 0.98 and a dramatically increasing risk of gallstone formation at rates of weight loss above 1.5 kg per week.
CONCLUSION: Risk of gallstone formation in obese persons during active weight loss seems to increase in an exponential fashion. The data suggest that rates of weight loss should not exceed an average of 1.5 kg per week.

Entities:  

Mesh:

Year:  1995        PMID: 7847427     DOI: 10.1016/S0002-9343(99)80394-5

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  22 in total

Review 1.  Cholesterol gallstones: from epidemiology to prevention.

Authors:  M Acalovschi
Journal:  Postgrad Med J       Date:  2001-04       Impact factor: 2.401

2.  Determinants of gallbladder kinetics in obesity.

Authors:  E M H Mathus-Vliegen; M L Van Ierland-Van Leeuwen; A Terpstra
Journal:  Dig Dis Sci       Date:  2004-01       Impact factor: 3.199

Review 3.  Nonalcoholic fatty liver disease: a clinical review.

Authors:  David A Sass; Parke Chang; Kapil B Chopra
Journal:  Dig Dis Sci       Date:  2005-01       Impact factor: 3.199

4.  Incidence of Gallstone Formation and Cholecystectomy 10 Years After Bariatric Surgery.

Authors:  Andreas Melmer; Wolfgang Sturm; Bernhard Kuhnert; Julia Engl-Prosch; Claudia Ress; Alexander Tschoner; Markus Laimer; Elisabeth Laimer; Matthias Biebl; Johann Pratschke; Herbert Tilg; Christoph Ebenbichler
Journal:  Obes Surg       Date:  2015-07       Impact factor: 4.129

5.  Gastrointestinal issues in the assessment and management of the obese patient.

Authors:  Zulfiqar Hussain; Eamonn M M Quigley
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-07

Review 6.  The Role of Diet in the Pathogenesis of Cholesterol Gallstones.

Authors:  Agostino Di Ciaula; Gabriella Garruti; Gema Frühbeck; Maria De Angelis; Ornella de Bari; David Q-H Wang; Frank Lammert; Piero Portincasa
Journal:  Curr Med Chem       Date:  2019       Impact factor: 4.530

7.  Ten-Hour Time-Restricted Eating Reduces Weight, Blood Pressure, and Atherogenic Lipids in Patients with Metabolic Syndrome.

Authors:  Michael J Wilkinson; Emily N C Manoogian; Adena Zadourian; Hannah Lo; Savannah Fakhouri; Azarin Shoghi; Xinran Wang; Jason G Fleischer; Saket Navlakha; Satchidananda Panda; Pam R Taub
Journal:  Cell Metab       Date:  2019-12-05       Impact factor: 27.287

8.  Gallstones and cholecystectomy in modern Britain.

Authors:  M C Bateson
Journal:  Postgrad Med J       Date:  2000-11       Impact factor: 2.401

9.  Gallbladder motility and lithogenesis in obese patients during diet-induced weight loss.

Authors:  R Zapata; C Severín; M Manríquez; V Valdivieso
Journal:  Dig Dis Sci       Date:  2000-02       Impact factor: 3.199

Review 10.  Metabolic syndrome in the elderly.

Authors:  Matthew Bechtold; John Palmer; Joshua Valtos; Catherine Iasiello; James Sowers
Journal:  Curr Diab Rep       Date:  2006-02       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.